Less Ads, More Data, More Tools Register for FREE

Dechra Pharma selects Alison Platt as next chair

Fri, 19th Nov 2021 07:34
(Sharecast News) - Dechra Pharmaceuticals has selected Alison Platt to chair the board when Tony Rice steps down at the end of 2021.
Platt has been a non-executive director at Dechra since March 2020 and sits on the boards of Tesco and Spectrum. She is also chair of Legal & General Financial Advice.

Rice announced his retirement in September after five years as chairman of the veterinary pharmaceuticals group and will hand over to Platt on 31 December. Denise Goode, a non-executive director, has resigned and will leave the board at the end of November.

Ian Page, Dechra's chief executive, said: "Since joining us in 2020 Alison has gained a good understanding of Dechra and our culture. Her extensive leadership experience and skills will further enhance the team's capabilities. I would also like to acknowledge Tony's contribution to the development of the group. We wish him all the best."

Shares in this article

Related News

IN BRIEF: Persimmon to replace outbound FTSE 100 constituent Dechra
12 Jan 2024

IN BRIEF: Persimmon to replace outbound FTSE 100 constituent Dechra

Persimmon PLC - York, England-based housebuilder - To rejoin FTSE 100 index on Tuesday as acquisition of Cheshire, England-based veterinary drug maker...

Persimmon + 1 more share
IN BRIEF: EU clears Dechra Pharmaceuticals takeover by EQT funds
27 Dec 2023

IN BRIEF: EU clears Dechra Pharmaceuticals takeover by EQT funds

Dechra Pharmaceuticals PLC - Cheshire, England-based veterinary drug maker - European Commission on Friday clears takeover of Dechra by funds managed ...